{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:26:38Z","timestamp":1787095598696,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"China Postdoctoral Science Foundation Funded Project"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Grant of Guangdong Provincial Key Laboratory of Psychiatric Disorders"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Comorbidity of depression and anxiety disorders (DAs) is as high as 50%, and diagnosis remains heavily reliant on subjective symptomatic assessments due to the lack of validated objective biomarkers. Neuroinflammation and oxidative stress are well-recognized core pathophysiological features of DAs. Prostaglandins (PGs), a class of lipid mediators closely linked to neuroinflammation and oxidative stress, have been implicated as key mediators in the pathogenesis of mood and anxiety disorders. S-(PGJ\u2082)-glutathione, a covalent conjugate of 15d-PGJ\u2082 and glutathione (GSH), integrates PG-mediated inflammatory signaling and GSH-dependent antioxidant defense, suggesting its potential as a candidate biomarker for DAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The case-control study enrolled 77 participants, including 39 patients with comorbid depression and anxiety disorders (DAs) and 38 healthy controls (HCs) matched for gender, age, and body mass index (BMI). The cohort was randomly stratified into training and test sets at a 7:3 ratio. Serum levels of PG-related metabolites were quantified using liquid chromatography-tandem mass spectrometry (LC-MS\/MS). Univariate and multivariate logistic regression analyses were performed in the training set to identify independent biomarkers. Receiver operating characteristic (ROC) analysis was employed to assess diagnostic performance in the training cohort, test cohort, and overall population, while decision curve analysis (DCA) was used to evaluate clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 21 PG-related metabolites were detected, of which five were significantly dysregulated in DAs patients and remained significant after FDR correction for multiple testing. Multivariate logistic regression identified S-(PGJ\u2082)-glutathione as an independent biomarker associated with DAs, both before and after adjustment for confounding factors including education level, systolic blood pressure (SBP), and diastolic blood pressure (DBP). ROC analysis in the total cohort showed that S-(PGJ\u2082)-glutathione yielded an AUC of 0.949, with a sensitivity of 0.789 and specificity of 0.949. Consistent results were observed in the training and internal test sets. DCA suggested that using S-(PGJ\u2082)-glutathione for diagnosis may provide a higher net benefit than conventional \u201cTreat All\u201d or \u201cTreat None\u201d strategies over a wide range of threshold probabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The PG metabolic pathway is dysregulated in patients with DAs. S-(PGJ\u2082)-glutathione is significantly downregulated and exhibits favorable preliminary diagnostic efficacy based on internal training and test set validation. Given the relatively small sample size and the absence of external cohort validation, these findings should be interpreted as preliminary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-08276-7","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:13:36Z","timestamp":1781198016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral S-(PGJ2)-glutathione as a diagnostic biomarker for depression-anxiety comorbidity: development and validation"],"prefix":"10.1186","volume":"26","author":[{"given":"Yan","family":"Zhen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xigao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengtao","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"1","key":"8276_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41398-018-0245-0","volume":"8","author":"JJ Chen","year":"2018","unstructured":"Chen JJ, et al. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Translational psychiatry. 2018;8(1):192.","journal-title":"Translational psychiatry"},{"issue":"10","key":"8276_CR2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1176\/ajp.153.10.1293","volume":"153","author":"C Brown","year":"1996","unstructured":"Brown C, et al. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry. 1996;153(10):1293\u2013300.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"8276_CR3","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.4088\/JCP.v67n0803","volume":"67","author":"TP McLaughlin","year":"2006","unstructured":"McLaughlin TP, et al. Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization. J Clin Psychiatry. 2006;67(8):1187\u201393.","journal-title":"J Clin Psychiatry"},{"key":"8276_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1192\/bjp.176.3.229","volume":"176","author":"PP Roy-Byrne","year":"2000","unstructured":"Roy-Byrne PP, et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J psychiatry: J mental Sci. 2000;176:229\u201335.","journal-title":"Br J psychiatry: J mental Sci"},{"key":"8276_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jad.2024.01.274","volume":"352","author":"GX Liu","year":"2024","unstructured":"Liu GX, et al. NEFA can serve as good biological markers for the diagnosis of depression in adolescents. J Affect Disord. 2024;352:342\u20138.","journal-title":"J Affect Disord"},{"issue":"1","key":"8276_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22\u201334.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"8276_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/PSY.0b013e318219e64e","volume":"73","author":"G Einvik","year":"2011","unstructured":"Einvik G, et al. Major depressive disorder, anxiety disorders, and cardiac biomarkers in subjects at high risk of obstructive sleep apnea. Psychosom Med. 2011;73(5):378\u201384.","journal-title":"Psychosom Med"},{"issue":"2","key":"8276_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/1570159X11666131120230309","volume":"12","author":"S Salim","year":"2014","unstructured":"Salim S. Oxidative stress and psychological disorders. Curr Neuropharmacol. 2014;12(2):140\u20137.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"8276_CR9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1037\/a0035302","volume":"140","author":"GM Slavich","year":"2014","unstructured":"Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140(3):774\u2013815.","journal-title":"Psychol Bull"},{"issue":"1","key":"8276_CR10","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1186\/s12888-025-07478-9","volume":"25","author":"RJ Peng","year":"2025","unstructured":"Peng RJ, et al. Oxidative stress and cognitive function in Chinese patients with major depressive disorder: the mediating role of depression severity. BMC Psychiatry. 2025;25(1):1012.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"8276_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s11033-019-05129-3","volume":"47","author":"E Pitsillou","year":"2020","unstructured":"Pitsillou E, et al. The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression. Mol Biol Rep. 2020;47(1):753\u201370.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"8276_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12974-022-02492-0","volume":"19","author":"H Wang","year":"2022","unstructured":"Wang H, et al. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflammation. 2022;19(1):132.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"8276_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0889-1591(02)00009-0","volume":"16","author":"H Anisman","year":"2002","unstructured":"Anisman H, Merali Z. Cytokines, stress, and depressive illness. Brain Behav Immun. 2002;16(5):513\u201324.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"8276_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/npp.2011.205","volume":"37","author":"E Haroon","year":"2012","unstructured":"Haroon E, et al. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol. 2012;37(1):137\u201362.","journal-title":"Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol"},{"issue":"3","key":"8276_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bpobgyn.2010.10.016","volume":"25","author":"GJ Burton","year":"2011","unstructured":"Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):287\u201399.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"8276_CR16","first-page":"956","volume":"20","author":"VI Lushchak","year":"2021","unstructured":"Lushchak VI, Storey KB. Oxidative stress concept updated: Definitions, classifications, and regulatory pathways implicated. EXCLI J. 2021;20:956\u201367.","journal-title":"EXCLI J"},{"key":"8276_CR17","doi-asserted-by":"crossref","unstructured":"Singh A, et al. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules. 2019;24(8).","DOI":"10.3390\/molecules24081583"},{"key":"8276_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-030-21735-8_8","volume":"1161","author":"PJ Kingsley","year":"2019","unstructured":"Kingsley PJ, et al. Aspects of Prostaglandin Glycerol Ester Biology. Adv Exp Med Biol. 2019;1161:77\u201388.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"8276_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/BF01133779","volume":"3","author":"B Samuelsson","year":"1983","unstructured":"Samuelsson B. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982. Biosci Rep. 1983;3(9):791\u2013813.","journal-title":"Biosci Rep"},{"issue":"14","key":"8276_CR20","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2174\/138161208784480243","volume":"14","author":"N Muller","year":"2008","unstructured":"Muller N, Schwarz MJ. COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des. 2008;14(14):1452\u201365.","journal-title":"Curr Pharm Des"},{"issue":"25","key":"8276_CR21","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2023.10.025","volume":"186","author":"D Sang","year":"2023","unstructured":"Sang D, et al. Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals. Cell. 2023;186(25):5500\u2013e1621.","journal-title":"Cell"},{"issue":"1","key":"8276_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/nyas.12987","volume":"1363","author":"ME Figueiredo-Pereira","year":"2016","unstructured":"Figueiredo-Pereira ME, et al. Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration. Ann N Y Acad Sci. 2016;1363(1):125\u201337.","journal-title":"Ann N Y Acad Sci"},{"key":"8276_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-2094-6-18","volume":"6","author":"SR Pierre","year":"2009","unstructured":"Pierre SR, et al. Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson\u2019s disease in mice. J Neuroinflammation. 2009;6:18.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"8276_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/med.1006","volume":"21","author":"DS Straus","year":"2001","unstructured":"Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev. 2001;21(3):185\u2013210.","journal-title":"Med Res Rev"},{"key":"8276_CR25","first-page":"104","volume":"7","author":"ME Figueiredo-Pereira","year":"2014","unstructured":"Figueiredo-Pereira ME, et al. Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Front Mol Neurosci. 2014;7:104.","journal-title":"Front Mol Neurosci"},{"issue":"4596","key":"8276_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.6836290","volume":"220","author":"A Meister","year":"1983","unstructured":"Meister A. Selective modification of glutathione metabolism. Science. 1983;220(4596):472\u20137.","journal-title":"Science"},{"issue":"3\u20134","key":"8276_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","volume":"57","author":"DM Townsend","year":"2003","unstructured":"Townsend DM, et al. The importance of glutathione in human disease. Biomed Pharmacother. 2003;57(3\u20134):145\u201355.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"8276_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00213-014-3687-y","volume":"232","author":"BR Godlewska","year":"2015","unstructured":"Godlewska BR, et al. Neurochemistry of major depression: a study using magnetic resonance spectroscopy. Psychopharmacology. 2015;232(3):501\u20137.","journal-title":"Psychopharmacology"},{"key":"8276_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neubiorev.2020.03.015","volume":"114","author":"I Zalachoras","year":"2020","unstructured":"Zalachoras I, et al. Therapeutic potential of glutathione-enhancers in stress-related psychopathologies. Neurosci Biobehav Rev. 2020;114:134\u201355.","journal-title":"Neurosci Biobehav Rev"},{"key":"8276_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cbi.2018.08.023","volume":"294","author":"S Dasari","year":"2018","unstructured":"Dasari S, et al. Role of glutathione S-transferases in detoxification of a polycyclic aromatic hydrocarbon, methylcholanthrene. Chem Biol Interact. 2018;294:81\u201390.","journal-title":"Chem Biol Interact"},{"issue":"47","key":"8276_CR31","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","volume":"22","author":"DM Townsend","year":"2003","unstructured":"Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003;22(47):7369\u201375.","journal-title":"Oncogene"},{"key":"8276_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1289\/ehp.834959","volume":"49","author":"B Ketterer","year":"1983","unstructured":"Ketterer B, et al. The role of glutathione in detoxication. Environ Health Perspect. 1983;49:59\u201369.","journal-title":"Environ Health Perspect"},{"issue":"1914","key":"8276_CR33","doi-asserted-by":"publisher","first-page":"20230365","DOI":"10.1098\/rstb.2023.0365","volume":"379","author":"N Micic","year":"2024","unstructured":"Micic N, et al. Overlooked and misunderstood: can glutathione conjugates be clues to understanding plant glutathione transferases? Philos Trans R Soc Lond B Biol Sci. 2024;379(1914):20230365.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"8276_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1021\/tx9601770","volume":"10","author":"JJ Bogaards","year":"1997","unstructured":"Bogaards JJ, et al. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1. Chem Res Toxicol. 1997;10(3):310\u20137.","journal-title":"Chem Res Toxicol"},{"issue":"1\u20132","key":"8276_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.prostaglandins.2012.03.004","volume":"98","author":"C Miyamoto","year":"2012","unstructured":"Miyamoto C, et al. Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors. Prostaglandins Other Lipid Mediat. 2012;98(1\u20132):17\u201322.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"4","key":"8276_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00213-024-06735-1","volume":"242","author":"CJM Bell","year":"2025","unstructured":"Bell CJM, et al. Glutathione alterations in depression: a meta-analysis and systematic review of proton magnetic resonance spectroscopy studies. Psychopharmacology. 2025;242(4):717\u201324.","journal-title":"Psychopharmacology"},{"issue":"3","key":"8276_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000544963","volume":"84","author":"L Cui","year":"2025","unstructured":"Cui L, et al. Oxidative Stress Markers Predict Treatment Outcomes in Patients with Generalized Anxiety Disorder Treated with Selective Serotonin Reuptake Inhibitors. Neuropsychobiology. 2025;84(3):146\u201357.","journal-title":"Neuropsychobiology"},{"issue":"1","key":"8276_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/bmc.1374","volume":"24","author":"IA Blair","year":"2010","unstructured":"Blair IA. Analysis of endogenous glutathione-adducts and their metabolites. Biomedical chromatography: BMC. 2010;24(1):29\u201338.","journal-title":"Biomedical chromatography: BMC"},{"key":"8276_CR39","doi-asserted-by":"crossref","unstructured":"Zhen Y, et al. Serum cyclic pentapeptide Cyclo(D-Trp-D-Asp-Pro-D-Val-Leu) as a candidate diagnostic biomarker for depression-anxiety comorbidity. Curr Neuropharmacol. 2026.","DOI":"10.2174\/011570159X439722260130231831"},{"issue":"1","key":"8276_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"8276_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50\u20135.","journal-title":"Br J Med Psychol"},{"key":"8276_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jad.2023.02.150","volume":"330","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Depressive symptoms, anxiety and social stress are associated with diminished cardiovascular reactivity in a psychological treatment-naive population. J Affect Disord. 2023;330:346\u201354.","journal-title":"J Affect Disord"},{"issue":"8","key":"8276_CR43","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/HYPERTENSIONAHA.123.22571","volume":"81","author":"FE Metlock","year":"2024","unstructured":"Metlock FE, et al. Impact of Social Determinants of Health on Hypertension Outcomes: A Systematic Review. Hypertension. 2024;81(8):1675\u2013700.","journal-title":"Hypertension"},{"issue":"5","key":"8276_CR44","doi-asserted-by":"publisher","first-page":"e13535","DOI":"10.1111\/psyp.13535","volume":"57","author":"X Yang","year":"2020","unstructured":"Yang X, et al. Cardiac vagal control mediates the relation between past depression and blood pressure several years later among young adults. Psychophysiology. 2020;57(5):e13535.","journal-title":"Psychophysiology"},{"issue":"6","key":"8276_CR45","doi-asserted-by":"publisher","first-page":"e70615","DOI":"10.1002\/brb3.70615","volume":"15","author":"C Yang","year":"2025","unstructured":"Yang C, et al. Association Between Education Levels and Sedentary Behavior With Depression Among US Adults. Brain Behav. 2025;15(6):e70615.","journal-title":"Brain Behav"},{"issue":"6","key":"8276_CR46","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/15321819.2025.2567856","volume":"46","author":"SB CetIn","year":"2025","unstructured":"CetIn SB, et al. Oxidative-antioxidative balance and stromal cell-derived factor-4 in generalized anxiety disorder: implications for pathophysiology and biomarker potential. J Immunoass Immunochem. 2025;46(6):654\u201366.","journal-title":"J Immunoass Immunochem"},{"issue":"7","key":"8276_CR47","doi-asserted-by":"publisher","first-page":"e70645","DOI":"10.1002\/brb3.70645","volume":"15","author":"O Hursitoglu","year":"2025","unstructured":"Hursitoglu O, et al. Serum Nox1 and Gper Levels in Patients With Generalized Anxiety Disorder: A Cross-Sectional Study in Turkiye. Brain Behav. 2025;15(7):e70645.","journal-title":"Brain Behav"},{"issue":"4","key":"8276_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neures.2010.08.007","volume":"68","author":"I Hovatta","year":"2010","unstructured":"Hovatta I, et al. Oxidative stress in anxiety and comorbid disorders. Neurosci Res. 2010;68(4):261\u201375.","journal-title":"Neurosci Res"},{"key":"8276_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/NDT.S444506","volume":"20","author":"M Oktay","year":"2024","unstructured":"Oktay M, et al. Biological Markers in Newly Diagnosed Generalized Anxiety Disorder Patients: 8-OHdG, S100B and Oxidative Stress. Neuropsychiatr Dis Treat. 2024;20:19\u201324.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"8276_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12991-025-00605-6","volume":"24","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, et al. Discrimination of first-onset patients with bipolar disorder or major depressive disorder using screened biochemical parameters. Ann Gen Psychiatry. 2025;24(1):61.","journal-title":"Ann Gen Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08276-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:16:39Z","timestamp":1787094999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08276-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8276"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08276-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1975 Declaration of Helsinki, as revised in 2013. This study was formally reviewed and approved by the Ethics committee of the Affiliated Brain Hospital of Guangzhou Medical University (Approval Date: June 17, 2019; Approval Reference Number: 2019-016). No waiver of ethical approval was involved in this study. All participants provided written informed consent prior to enrollment and sample collection.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No individual person\u2019s data (e.g., images, videos, or clinical details) are presented in this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, the authors used Doubao (ByteDance, 2026) and DeepSeek-V3.2 for English language polishing, grammatical optimization and academic expression refinement; these AI tools were not applied to generate core research content including study design, data analysis, result interpretation and original conclusions. All authors have thoroughly reviewed, revised and verified the AI-assisted content, and take full responsibility for the accuracy, originality and academic integrity of this manuscript.","order":3,"name":"Ethics","label":"Declaration of AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"643"}}